How To Read The UK’s New Medical Device Regulations: MHRA Explains The Main Points
The UK’s 2019 medtech regulations laid in Parliament last week in preparation for a possible no-deal Brexit at the end of March are long and difficult to read. Medtech Insight spoke to the Medicines and Healthcare products Regulatory Agency to find out the essentials.
You may also be interested in...
There is now even more urgency for medtech companies, including small firms, to employ the services of EU27 notified bodies – with UK notified bodies set to have their conformity assessment roles temporarily withdrawn if the UK leaves on March 29 without a deal.
A new general UK safety mark, the UKCA, is being introduced to replace the CE mark in the event of a no-deal Brexit. How does this fit withthe latest promise for UK to continue accepting CE marks for medtech?
With the UK still wallowing in uncertainty over Brexit, the government has been forced hit the ground running in January by issuing various documents spelling out in greater detail what will need to happen in the case of a "no-deal" Brexit, which is looking increasingly possible. What does medtech need to know?